ABT-510/Thrombospondin-1 mimetic

TERMINATED · PHASE2 · Carcinoma, Non-Small-Cell Lung

Enrollment suspended based upon interim analysis; subjects allowed to stay on study until disease progression.

Scientific benefit, asset-specific safety, ownership and licensing: Unknown without reviewed evidence.

Detailed evidence is available in the local Pro plan simulation.